Impact of distal or pylorus preserving gastrectomy on postoperative quality of life in T1 stage middle third gastric cancer patients

Abstract Pylorus-preserving gastrectomy (PPG) and distal gastrectomy (DG) are widely utilized surgical approaches for the treatment of gastric cancer. In this study, we employed questionnaire surveys and follow-up assessments to examine the effects of these surgical procedures on postoperative quali...

Full description

Saved in:
Bibliographic Details
Main Authors: Hao Chen, Siqing Jing, Zhaoping Li, Lianlian Cao, Wenxian Guan, Xin Chen, Meng Wang
Format: Article
Language:English
Published: Nature Portfolio 2025-03-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-90866-8
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849773943566630912
author Hao Chen
Siqing Jing
Zhaoping Li
Lianlian Cao
Wenxian Guan
Xin Chen
Meng Wang
author_facet Hao Chen
Siqing Jing
Zhaoping Li
Lianlian Cao
Wenxian Guan
Xin Chen
Meng Wang
author_sort Hao Chen
collection DOAJ
description Abstract Pylorus-preserving gastrectomy (PPG) and distal gastrectomy (DG) are widely utilized surgical approaches for the treatment of gastric cancer. In this study, we employed questionnaire surveys and follow-up assessments to examine the effects of these surgical procedures on postoperative quality of life and pancreatic exocrine function in patients with stage T1 middle-third gastric cancer. A retrospective cohort study was conducted to analyze clinical and follow-up data from 63 gastric cancer patients who underwent distal gastrectomy and 21 who underwent pylorus-preserving gastrectomy at Nanjing University Drum Tower Hospital between January 2019 and January 2023. Patients were categorized into two groups: distal gastrectomy (n = 63) and pylorus-preserving gastrectomy (n = 21). The primary outcome measure was postoperative quality of life assessed at 1 year using the Gastric Resection Syndrome Assessment Scale, Gastroparesis Cardinal Symptom Index (GSCI), and Pancreatic Exocrine Insufficiency Questionnaire (PEI-Q). Secondary outcomes included intraoperative and postoperative conditions, incidence of complications, and changes in nutritional status at 6 and 12 months post-surgery. Compared to the DG group, the PPG group exhibited fewer lymph node dissections [20 (17, 26) vs. 25 (19.5, 32), Z = 2.013, P = 0.052], shorter distances from the upper resection margin [2.0 (1.3, 3.0) vs. 3.5 (2.5, 4.75), Z = 4.664, P = 0.0002], and shorter distances from the lower resection margin [2.0 (1.4, 3.0) vs. 4.5 (4.0, 5.5), Z = 6.691, P < 0.001]. However, they experienced longer operative times [270 (240, 300) vs. 220 (187.5, 257.5), Z = 4.133, P = 0.0002], postoperative gas discharge times [4 (4, 5) vs. 4 (3, 4), Z = 5.96, P < 0.0001], and postoperative hospital stays [12 (10, 14) vs. 10 (9, 12), Z = 1.493, P = 0.0098]. One year postoperatively, patients in the PPG group demonstrated superior quality of life scores compared to the DG group in terms of the dumping symptom scale [1.0 (1.0, 1.33) vs. 2.5 (1.75, 2.5), Z = 7.192, P < 0.001], amount of food intake per meal [6 (6, 7) vs. 6 (4, 6), Z = 4.724, P = 0.0008], and meal quality scale [4.0 (3.67, 4.0) vs. 2.33 (1.67, 2.67), Z = 11.554, P < 0.0001]. Additionally, preoperative serum albumin levels were higher in the PPG group compared to the DG group [41.7 (40.3, 43) vs. 40.2 (39.15, 41.3), Z = 2.916, P = 0.006], and the PPG group had a lower rate of postoperative chemotherapy requirement (P = 0.024). Compared to distal gastrectomy (DG), pylorus-preserving gastrectomy (PPG) results in fewer dumping symptoms and an improved quality of life for patients following surgery. This makes PPG a highly favorable surgical option for treating stage T1 middle-third gastric cancer.
format Article
id doaj-art-e4c4b1500f8c4e838e3833dba13b754a
institution DOAJ
issn 2045-2322
language English
publishDate 2025-03-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-e4c4b1500f8c4e838e3833dba13b754a2025-08-20T03:01:54ZengNature PortfolioScientific Reports2045-23222025-03-011511910.1038/s41598-025-90866-8Impact of distal or pylorus preserving gastrectomy on postoperative quality of life in T1 stage middle third gastric cancer patientsHao Chen0Siqing Jing1Zhaoping Li2Lianlian Cao3Wenxian Guan4Xin Chen5Meng Wang6Division of Gastric Surgery, Department of General Surgery, Affiliated Hospital of Medical School, Nanjing Drum Tower Hospital, Nanjing UniversityDivision of Gastric Surgery, Department of General Surgery, Affiliated Hospital of Medical School, Nanjing Drum Tower Hospital, Nanjing UniversityDivision of Gastric Surgery, Department of General Surgery, Drum Tower Clinical Medical College, Nanjing Drum Tower Hospital, Nanjing University of Chinese MedicineDivision of Gastric Surgery, Department of General Surgery, Drum Tower Clinical Medical College, Nanjing Drum Tower Hospital, Nanjing University of Chinese MedicineDivision of Gastric Surgery, Department of General Surgery, Affiliated Hospital of Medical School, Nanjing Drum Tower Hospital, Nanjing UniversityDivision of Gastric Surgery, Department of General Surgery, Affiliated Hospital of Medical School, Nanjing Drum Tower Hospital, Nanjing UniversityDivision of Gastric Surgery, Department of General Surgery, Affiliated Hospital of Medical School, Nanjing Drum Tower Hospital, Nanjing UniversityAbstract Pylorus-preserving gastrectomy (PPG) and distal gastrectomy (DG) are widely utilized surgical approaches for the treatment of gastric cancer. In this study, we employed questionnaire surveys and follow-up assessments to examine the effects of these surgical procedures on postoperative quality of life and pancreatic exocrine function in patients with stage T1 middle-third gastric cancer. A retrospective cohort study was conducted to analyze clinical and follow-up data from 63 gastric cancer patients who underwent distal gastrectomy and 21 who underwent pylorus-preserving gastrectomy at Nanjing University Drum Tower Hospital between January 2019 and January 2023. Patients were categorized into two groups: distal gastrectomy (n = 63) and pylorus-preserving gastrectomy (n = 21). The primary outcome measure was postoperative quality of life assessed at 1 year using the Gastric Resection Syndrome Assessment Scale, Gastroparesis Cardinal Symptom Index (GSCI), and Pancreatic Exocrine Insufficiency Questionnaire (PEI-Q). Secondary outcomes included intraoperative and postoperative conditions, incidence of complications, and changes in nutritional status at 6 and 12 months post-surgery. Compared to the DG group, the PPG group exhibited fewer lymph node dissections [20 (17, 26) vs. 25 (19.5, 32), Z = 2.013, P = 0.052], shorter distances from the upper resection margin [2.0 (1.3, 3.0) vs. 3.5 (2.5, 4.75), Z = 4.664, P = 0.0002], and shorter distances from the lower resection margin [2.0 (1.4, 3.0) vs. 4.5 (4.0, 5.5), Z = 6.691, P < 0.001]. However, they experienced longer operative times [270 (240, 300) vs. 220 (187.5, 257.5), Z = 4.133, P = 0.0002], postoperative gas discharge times [4 (4, 5) vs. 4 (3, 4), Z = 5.96, P < 0.0001], and postoperative hospital stays [12 (10, 14) vs. 10 (9, 12), Z = 1.493, P = 0.0098]. One year postoperatively, patients in the PPG group demonstrated superior quality of life scores compared to the DG group in terms of the dumping symptom scale [1.0 (1.0, 1.33) vs. 2.5 (1.75, 2.5), Z = 7.192, P < 0.001], amount of food intake per meal [6 (6, 7) vs. 6 (4, 6), Z = 4.724, P = 0.0008], and meal quality scale [4.0 (3.67, 4.0) vs. 2.33 (1.67, 2.67), Z = 11.554, P < 0.0001]. Additionally, preoperative serum albumin levels were higher in the PPG group compared to the DG group [41.7 (40.3, 43) vs. 40.2 (39.15, 41.3), Z = 2.916, P = 0.006], and the PPG group had a lower rate of postoperative chemotherapy requirement (P = 0.024). Compared to distal gastrectomy (DG), pylorus-preserving gastrectomy (PPG) results in fewer dumping symptoms and an improved quality of life for patients following surgery. This makes PPG a highly favorable surgical option for treating stage T1 middle-third gastric cancer.https://doi.org/10.1038/s41598-025-90866-8Pylorus-preserving gastrectomyDistal gastrectomyGastric cancerStomach neoplasmsSurgeryQuality of life
spellingShingle Hao Chen
Siqing Jing
Zhaoping Li
Lianlian Cao
Wenxian Guan
Xin Chen
Meng Wang
Impact of distal or pylorus preserving gastrectomy on postoperative quality of life in T1 stage middle third gastric cancer patients
Scientific Reports
Pylorus-preserving gastrectomy
Distal gastrectomy
Gastric cancer
Stomach neoplasms
Surgery
Quality of life
title Impact of distal or pylorus preserving gastrectomy on postoperative quality of life in T1 stage middle third gastric cancer patients
title_full Impact of distal or pylorus preserving gastrectomy on postoperative quality of life in T1 stage middle third gastric cancer patients
title_fullStr Impact of distal or pylorus preserving gastrectomy on postoperative quality of life in T1 stage middle third gastric cancer patients
title_full_unstemmed Impact of distal or pylorus preserving gastrectomy on postoperative quality of life in T1 stage middle third gastric cancer patients
title_short Impact of distal or pylorus preserving gastrectomy on postoperative quality of life in T1 stage middle third gastric cancer patients
title_sort impact of distal or pylorus preserving gastrectomy on postoperative quality of life in t1 stage middle third gastric cancer patients
topic Pylorus-preserving gastrectomy
Distal gastrectomy
Gastric cancer
Stomach neoplasms
Surgery
Quality of life
url https://doi.org/10.1038/s41598-025-90866-8
work_keys_str_mv AT haochen impactofdistalorpyloruspreservinggastrectomyonpostoperativequalityoflifeint1stagemiddlethirdgastriccancerpatients
AT siqingjing impactofdistalorpyloruspreservinggastrectomyonpostoperativequalityoflifeint1stagemiddlethirdgastriccancerpatients
AT zhaopingli impactofdistalorpyloruspreservinggastrectomyonpostoperativequalityoflifeint1stagemiddlethirdgastriccancerpatients
AT lianliancao impactofdistalorpyloruspreservinggastrectomyonpostoperativequalityoflifeint1stagemiddlethirdgastriccancerpatients
AT wenxianguan impactofdistalorpyloruspreservinggastrectomyonpostoperativequalityoflifeint1stagemiddlethirdgastriccancerpatients
AT xinchen impactofdistalorpyloruspreservinggastrectomyonpostoperativequalityoflifeint1stagemiddlethirdgastriccancerpatients
AT mengwang impactofdistalorpyloruspreservinggastrectomyonpostoperativequalityoflifeint1stagemiddlethirdgastriccancerpatients